Al Awamlh BAH, Wu X, Barocas DA, Moses KA, Hoffman RM, Basourakos SP, et al. Intensity of observation with active surveillance or watchful waiting in men with prostate cancer in the United States. Prostate Cancer Prostatic Dis. 2022. https://doi.org/10.1038/s41391-022-00580-z. [Epub ahead of print].
Johansson JE, Andren O, Andersson SO, Dickman PW, Holmberg L, Magnuson A, et al. Natural history of early localized prostate cancer. JAMA. 2004;291:2713–9.
Albertsen PC, Hanley JA, Fine J. 20 year outcomes following conservative management of clinically localized prostate cancer. JAMA. 2005;293:2095–101.
Bill-Axelson A, Holmberg L, Ruutu M, Garmo H, Stark JR, Busch C, et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Eng J Med. 2011;364:1708–17.
Wilt TJ, Brawer MK, Jones KM, Barry MJ, Aronson WJ, Fox S, et al. Radical prostatectomy versus observation for early prostate cancer. N Eng J Med. 2012;367:203–13.
Hamdy F, Donovan J, Lane JA, Mason M, Holding P, Davis M, et al. Mortality and clinical outcomes at 10 years’ follow up in the ProtecT trial. N Eng J Med. 2016;375:1415–142.
Martin RM, Donovan JL, Turner EL, Metcalfe C, Young GJ, Walsh EI, et al. Effect of low-intensity PSA-based screening intervention on prostate cancer mortality. JAMA. 2018;319:883–95.
Kasivisvanathan V, Rannikko AS, Borghi M, Panebianco V, Mynderse LA, Briganti A, et al. MRI targeted or standard biopsy for prostate cancer diagnosis. N Eng J Med. 2018;378:1767–77.
留言 (0)